These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29351331)

  • 21. Prevalence of Influenza Vaccination in Chronic Obstructive Pulmonary Disease Patients and Impact on the Risk of Severe Exacerbations.
    Garrastazu R; García-Rivero JL; Ruiz M; Helguera JM; Arenal S; Bonnardeux C; León C; Llorca J; Santibañez M
    Arch Bronconeumol; 2016 Feb; 52(2):88-95. PubMed ID: 26526292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of 1-year mortality at hospital admission for acute exacerbations of chronic obstructive pulmonary disease.
    Slenter RH; Sprooten RT; Kotz D; Wesseling G; Wouters EF; Rohde GG
    Respiration; 2013; 85(1):15-26. PubMed ID: 23037178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired Sleep Quality in COPD Is Associated With Exacerbations: The CanCOLD Cohort Study.
    Shorofsky M; Bourbeau J; Kimoff J; Jen R; Malhotra A; Ayas N; Tan WC; Aaron SD; Sin DD; Road J; Chapman KR; O'Donnell DE; Maltais F; Hernandez P; Walker BL; Marciniuk D; Kaminska M; ;
    Chest; 2019 Nov; 156(5):852-863. PubMed ID: 31150638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.
    Jones RC; Price D; Chavannes NH; Lee AJ; Hyland ME; Ställberg B; Lisspers K; Sundh J; van der Molen T; Tsiligianni I;
    NPJ Prim Care Respir Med; 2016 Apr; 26():16010. PubMed ID: 27053297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients.
    Soler-Cataluña JJ; Martínez-García MA; Sánchez LS; Tordera MP; Sánchez PR
    Respir Med; 2009 May; 103(5):692-9. PubMed ID: 19131231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of global initiative for chronic obstructive pulmonary disease 2013 classification and body mass index, airflow obstruction, dyspnea, and exacerbations index in predicting mortality and exacerbations in elderly adults with chronic obstructive pulmonary disease.
    Chen CZ; Ou CY; Yu CH; Yang SC; Chang HY; Hsiue TR
    J Am Geriatr Soc; 2015 Feb; 63(2):244-50. PubMed ID: 25641518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk indexes for exacerbations and hospitalizations due to COPD.
    Niewoehner DE; Lokhnygina Y; Rice K; Kuschner WG; Sharafkhaneh A; Sarosi GA; Krumpe P; Pieper K; Kesten S
    Chest; 2007 Jan; 131(1):20-8. PubMed ID: 17218552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Independent effect of prior exacerbation frequency and disease severity on the risk of future exacerbations of COPD: a retrospective cohort study.
    Margüello MS; Garrastazu R; Ruiz-Nuñez M; Helguera JM; Arenal S; Bonnardeux C; León C; Miravitlles M; García-Rivero JL
    NPJ Prim Care Respir Med; 2016 Sep; 26():16046. PubMed ID: 27604472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Right heart failure as a risk factor for severe exacerbation in patients with chronic obstructive pulmonary disease: Prospective cohort study.
    Orea-Tejeda A; Navarrete-Peñaloza AG; Verdeja-Vendrell L; Jiménez-Cepeda A; González-Islas DG; Hernández-Zenteno R; Keirns-Davis C; Sánchez-Santillán R; Velazquez-Montero A; Puentes Rodríguez G
    Clin Respir J; 2018 Dec; 12(12):2635-2641. PubMed ID: 30307708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. β-Blocker use and incidence of chronic obstructive pulmonary disease exacerbations.
    Farland MZ; Peters CJ; Williams JD; Bielak KM; Heidel RE; Ray SM
    Ann Pharmacother; 2013 May; 47(5):651-6. PubMed ID: 23585645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Iyer AS; Bhatt SP; Garner JJ; Wells JM; Trevor JL; Patel NM; Kirkpatrick d; Williams JC; Dransfield MT
    Ann Am Thorac Soc; 2016 Feb; 13(2):197-203. PubMed ID: 26599286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.
    Leuppi JD; Schuetz P; Bingisser R; Bodmer M; Briel M; Drescher T; Duerring U; Henzen C; Leibbrandt Y; Maier S; Miedinger D; Müller B; Scherr A; Schindler C; Stoeckli R; Viatte S; von Garnier C; Tamm M; Rutishauser J
    JAMA; 2013 Jun; 309(21):2223-31. PubMed ID: 23695200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group.
    Durheim MT; Smith PJ; Babyak MA; Mabe SK; Martinu T; Welty-Wolf KE; Emery CF; Palmer SM; Blumenthal JA
    Ann Am Thorac Soc; 2015 Mar; 12(3):349-56. PubMed ID: 25568929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare members.
    Pasquale MK; Xu Y; Baker CL; Zou KH; Teeter JG; Renda AM; Davis CC; Lee TC; Bobula J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():111-21. PubMed ID: 26834468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidental findings on chest CT imaging are associated with increased COPD exacerbations and mortality.
    Jairam PM; van der Graaf Y; Lammers JW; Mali WP; de Jong PA;
    Thorax; 2015 Aug; 70(8):725-31. PubMed ID: 26024687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
    Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease Trajectories and Impact of One Moderate Exacerbation in Gold B COPD Patients.
    Løkke A; Hilberg O; Lange P; Ibsen R; Stratelis G; de Fine Licht S; Lykkegaard J
    Int J Chron Obstruct Pulmon Dis; 2022; 17():569-578. PubMed ID: 35321533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mortality after an emergency department visit for exacerbation of chronic obstructive pulmonary disease.
    Kim S; Clark S; Camargo CA
    COPD; 2006 Jun; 3(2):75-81. PubMed ID: 17175669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting Severe Chronic Obstructive Pulmonary Disease Exacerbations. Developing a Population Surveillance Approach with Administrative Data.
    Tavakoli H; Chen W; Sin DD; FitzGerald JM; Sadatsafavi M
    Ann Am Thorac Soc; 2020 Sep; 17(9):1069-1076. PubMed ID: 32383971
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.